| Net Cash Provided by (Used in) Operating Activities |
$143,000,000 |
USD |
|
Q1 2025 |
Q1 2025 |
| Net Cash Provided by (Used in) Financing Activities |
$103,000,000 |
USD |
|
Q1 2025 |
Q1 2025 |
| Net Cash Provided by (Used in) Investing Activities |
$321,000,000 |
USD |
-415% |
Q1 2025 |
Q1 2025 |
| Common Stock, Shares Authorized |
111,000,000 |
shares |
0% |
Q4 2024 |
FY 2024 |
| Common Stock, Shares, Issued |
15,241,316 |
shares |
0.29% |
Q4 2024 |
FY 2024 |
| Common Stock, Par or Stated Value Per Share |
1 |
USD/shares |
0% |
Q4 2024 |
FY 2024 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
$73,000,000 |
USD |
-4.3% |
Q1 2025 |
Q1 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
$1,481,000,000 |
USD |
95% |
Q1 2025 |
Q1 2025 |
| Interest Paid, Excluding Capitalized Interest, Operating Activities |
$32,000,000 |
USD |
0% |
Q1 2025 |
Q1 2025 |
| Deferred Tax Assets, Valuation Allowance |
$124,000,000 |
USD |
-21% |
Q4 2024 |
FY 2024 |
| Deferred Tax Assets, Gross |
$543,000,000 |
USD |
-7.5% |
Q4 2024 |
FY 2024 |
| Comprehensive Income (Loss), Net of Tax, Attributable to Parent |
$596,000,000 |
USD |
-37% |
Q1 2025 |
Q1 2025 |
| Deferred Tax Assets, Operating Loss Carryforwards |
$242,000,000 |
USD |
19% |
Q4 2024 |
FY 2024 |
| Preferred Stock, Shares Authorized |
45,000,000 |
shares |
0% |
Q4 2024 |
FY 2024 |
| Unrecognized Tax Benefits |
$0 |
USD |
|
Q4 2024 |
FY 2024 |
| Additional Paid in Capital |
$599,000,000 |
USD |
2.4% |
Q1 2025 |
Q1 2025 |
| Deferred Tax Assets, Net of Valuation Allowance |
$419,000,000 |
USD |
-2.8% |
Q4 2024 |
FY 2024 |
| Interest Expense |
$90,000,000 |
USD |
1.1% |
Q1 2025 |
Q1 2025 |
| Preferred Stock, Par or Stated Value Per Share |
1 |
USD/shares |
0% |
Q4 2024 |
FY 2024 |